BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND IGH
310 results:

  • 1. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
    Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
    Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
    Huang F; Ruan Y; He X; Lian H; Yang J
    World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cell-free DNA for detection of clonal B cells in diffuse large B cell lymphoma by sequencing.
    Højlund EL; Cédile O; Larsen TS; Vimalathas G; Møller MB; Hansen MH; Nyvold CG
    Int J Lab Hematol; 2023 Oct; 45(5):735-742. PubMed ID: 37350020
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Divergent evolution of metachronous follicular lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue from a common precursor.
    Tzioni MM; Wotherspoon A; Chen Z; Cucco F; Makker J; Du MQ
    J Pathol; 2023 Sep; 261(1):11-18. PubMed ID: 37345526
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Insights into igh clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications.
    Darzentas F; Szczepanowski M; Kotrová M; Hartmann A; Beder T; Gökbuget N; Schwartz S; Bastian L; Baldus CD; Pál K; Darzentas N; Brüggemann M
    Front Immunol; 2023; 14():1125017. PubMed ID: 37143651
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Primary Cutaneous Marginal Zone Lymphoproliferative Disorder of Donor Origin after Allogeneic Hematopoietic Stem Cell Transplantation.
    Bejarano L; Sayagués JM; Alcoceba M; Balanzategui A; Lopez-Corral L; Cañueto J; Santos-Briz A
    Am J Dermatopathol; 2023 Jun; 45(6):378-382. PubMed ID: 37130208
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of long noncoding RNA
    Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
    Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
    Ravandi F; Kreitman RJ; Tiacci E; Andritsos L; Banerji V; Barrientos JC; Bhat SA; Blachly JS; Broccoli A; Call T; Chihara D; Dearden C; Demeter J; Dietrich S; Else M; Epperla N; Falini B; Forconi F; Gladstone DE; Gozzetti A; Iyengar S; Johnston JB; Jorgensen J; Juliusson G; Lauria F; Lozanski G; Parikh SA; Park JH; Polliack A; Quest G; Robak T; Rogers KA; Saven A; Seymour JF; Tadmor T; Tallman MS; Tam CS; Thompson PA; Troussard X; Zent CS; Zenz T; Zinzani PL; Wörmann B; Rai K; Grever M
    Blood Cancer J; 2022 Dec; 12(12):165. PubMed ID: 36509740
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Follicular lymphoma: 2023 update on diagnosis and management.
    Jacobsen E
    Am J Hematol; 2022 Dec; 97(12):1638-1651. PubMed ID: 36255040
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Role of immunoglobulin heavy and light chain gene rearrangement analysis in differentiating between benign and malignant bone marrow B-cell lymphoid aggregates.
    Evans MG; Brynes RK; Crymes A; Reid J; Haghighi N; Botros C; Zhao X; Rezk SA
    Hum Pathol; 2022 Dec; 130():58-64. PubMed ID: 36252861
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.
    Barnell EK; Skidmore ZL; Newcomer KF; Chavez M; Campbell KM; Cotto KC; Spies NC; Ruzinova MB; Wang T; Abro B; Kreisel F; Parikh BA; Duncavage EJ; Frater JL; Lee YS; Hassan A; King JA; Kohnen DR; Fiala MA; Welch JS; Uy GL; Vij K; Vij R; Griffith M; Griffith OL; Wartman LD
    Blood Adv; 2023 Jan; 7(2):236-245. PubMed ID: 36251745
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms.
    Qiu L; Nwogbo OV; Medeiros LJ; Thakral B; Li S; Xu J; You MJ; Wang W; Quesada AE; Ramos CB; McDonnell TJ; Thomas SK; Lin P
    Hum Pathol; 2022 Dec; 130():47-57. PubMed ID: 36244464
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Novel Integrated Approach for Cytogenomic Evaluation of Plasma Cell Neoplasms.
    Aarabi M; Yoest JM; Farah R; Rajkovic A; Swerdlow SH; Yatsenko SA
    J Mol Diagn; 2022 Oct; 24(10):1067-1078. PubMed ID: 35940519
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
    Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients.
    Albakova Z; Mangasarova Y; Albakov A; Nikulina E; Kravchenko S; Sapozhnikov A
    Front Immunol; 2022; 13():893137. PubMed ID: 35572591
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia.
    Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P
    Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Decrease of CD38 expression is linked to increase of solitary plasmacytoma pathological grade: a single institution experience from China.
    Li Y; Guo J; Yang C; Xu J; Meng P; Xiao SY
    Front Biosci (Landmark Ed); 2022 Jan; 27(1):21. PubMed ID: 35090326
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral bone Marrow Trephination for Detecting bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
    Kim M; Ahn SY; Ahn JS; Song GY; Jung SH; Lee JJ; Kim HJ; Lee JH; Shin MG; Song SY; Yang DH
    J Korean Med Sci; 2022 Jan; 37(1):e2. PubMed ID: 34981678
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mechanism of noncoding RNA-associated N
    Nair L; Zhang W; Laffleur B; Jha MK; Lim J; Lee H; Wu L; Alvarez NS; Liu ZP; Munteanu EL; Swayne T; Hanna JH; Ding L; Rothschild G; Basu U
    Mol Cell; 2021 Oct; 81(19):3949-3964.e7. PubMed ID: 34450044
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.